FGFR4-high expression is associated with an immune-responsive phenotype in HCCand predicts inferior efficacy of lenvatinib plus PD-1 blockade
Favorite
Share
More Options
12

Open in WPS to view all 12 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
